Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kadant | KAI | Nov 29, 2024 | 412.79 | +2.31 |
Kairos Pharma | KAPA | Nov 29, 2024 | 1.54 | 0.00 |
Kairous Acquisition | KACL | Nov 29, 2024 | 12.46 | 0.00 |
Kaiser Aluminium | KALU | Nov 29, 2024 | 81.28 | -0.47 |
Kaival Brands Innovations Group | KAVL | Nov 29, 2024 | 0.72 | -1.42 |
Kaixin Holdings | KXIN | Nov 29, 2024 | 1.96 | -1.01 |
Kala Bio | KALA | Nov 29, 2024 | 6.86 | +3.12 |
Kaltura | KLTR | Nov 29, 2024 | 2.22 | +2.78 |
KalVista Pharmaceuticals | KALV | Nov 29, 2024 | 10.06 | -0.30 |
Kamada | KMDA | Nov 29, 2024 | 5.89 | +1.38 |
Kandi Technologies Group | KNDI | Nov 29, 2024 | 1.23 | -2.38 |
Kanzhun ADR | BZ | Nov 29, 2024 | 13.50 | +7.31 |
Karat Packaging | KRT | Nov 29, 2024 | 30.89 | +1.41 |
Karooooo | KARO | Nov 29, 2024 | 44.80 | +0.99 |
Kartoon Studios | TOON | Nov 29, 2024 | 0.67 | +6.85 |
Karyopharm Therapeutics | KPTI | Nov 29, 2024 | 0.85 | -0.87 |
Katapult | KPLT | Nov 29, 2024 | 7.56 | +13.00 |
Kayne Anderson BDC | KBDC | Nov 29, 2024 | 16.75 | +0.90 |
Kayne Anderson Energy Infrastructure Fund | KYN | Nov 29, 2024 | 13.68 | +1.26 |
Kazia Therapeutics ADR | KZIA | Nov 29, 2024 | 5.17 | -5.31 |
KB Financial Group ADR | KB | Nov 29, 2024 | 68.93 | -2.63 |
KB Home | KBH | Nov 29, 2024 | 82.74 | -0.14 |
KBR | KBR | Nov 29, 2024 | 60.83 | -0.57 |
KBW Bank Powershares | KBWB | Nov 29, 2024 | 71.03 | -0.03 |
KBW High Div Yield Financial Powershares | KBWD | Nov 29, 2024 | 15.51 | +0.26 |
KBW Prem Yield Equity REIT Powershares | KBWY | Nov 29, 2024 | 20.01 | -0.35 |
KBW Prop & Casuality Insur Powershares | KBWP | Nov 29, 2024 | 126.38 | -0.02 |
KBW Regional Banking Powershares | KBWR | Nov 29, 2024 | 67.07 | -0.47 |
KE Holdings | BEKE | Nov 29, 2024 | 18.85 | -0.84 |
Kearny Financial | KRNY | Nov 29, 2024 | 7.92 | -0.13 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.